XML 131 R39.htm IDEA: XBRL DOCUMENT v3.24.4
Fair Value Measurements (Details) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Jun. 11, 2024
Mar. 22, 2024
Jan. 17, 2024
Sep. 30, 2024
Sep. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
Jun. 30, 2024
Fair Value Measurements [Line Items]                
Derivative liabilities       $ 19,266,715 $ 19,266,715    
Grant of fair value per share (in Dollars per share)           $ 6.29    
Aggregate value             $ 776,815  
Additional Shares (in Shares) 9,543,002 8,038,537 5,838,537   500,000      
Proceeds from liability $ 98,282              
Liability 3,500,369     21,405 $ 21,405      
Net liability 3,402,100              
Gain (loss) from the change in fair value of derivatives       $ 0        
Stock price (in Dollars per share)           $ 18    
FPA [Member]                
Fair Value Measurements [Line Items]                
Representative Shares (in Shares)           123,500    
Aggregate value           $ 776,815    
Series A Warrants [Member]                
Fair Value Measurements [Line Items]                
Fair value of warrants 6,502,710              
Gain (loss) from the change in fair value of derivatives         $ 17,820,998      
Exercise warrants shares (in Shares)       10,266,664 10,266,664      
Series B Warrants [Member]                
Fair Value Measurements [Line Items]                
Fair value of warrants $ 142,655              
Exercise warrants shares (in Shares)       25,666,660 25,666,660      
Stock price (in Dollars per share)       $ 0.15 $ 0.15      
Warrant [Member]                
Fair Value Measurements [Line Items]                
Gain (loss) from the change in fair value of derivatives       $ 5,383,585 $ 6,093,635      
Series C Warrants [Member]                
Fair Value Measurements [Line Items]                
Fair value of warrants       8,160,300 8,160,300      
Gain (loss) from the change in fair value of derivatives       $ 435,550 $ 9,654,799      
Exercise warrants shares (in Shares)       123,076,923 123,076,923      
Series D Warrants [Member]                
Fair Value Measurements [Line Items]                
Fair value of warrants       $ 1,058,950 $ 1,058,950      
Gain (loss) from the change in fair value of derivatives         $ (9,654,799)      
Exercise warrants shares (in Shares)       49,320,990 49,320,990      
Stock price (in Dollars per share)       $ 0.065 $ 0.065      
Forward Purchase Agreement [Member]                
Fair Value Measurements [Line Items]                
Derivative liabilities           35,576,596    
Proceeds from liability         $ 98,282      
Liability       $ 3,500,369 3,500,369      
Net liability               $ 3,402,100
Non-Redemption Agreement [Member]                
Fair Value Measurements [Line Items]                
Derivative liabilities           $ 11,152,000    
Series A Preferred Stock [Member]                
Fair Value Measurements [Line Items]                
Gain (loss) from the change in fair value of derivatives         $ 17,820,998      
Common Stock [Member]                
Fair Value Measurements [Line Items]                
Representative Shares (in Shares)         7,000,000      
Common Stock [Member] | Series A Warrants [Member]                
Fair Value Measurements [Line Items]                
Exercise warrants shares (in Shares)       466,000 466,000      
Common Stock [Member] | Series B Warrants [Member]                
Fair Value Measurements [Line Items]                
Exercise warrants shares (in Shares)       5,364,046 5,364,046      
Earnout Shares [Member]                
Fair Value Measurements [Line Items]                
Stock price (in Dollars per share)       $ 4.53 $ 4.53      
Risk free rate         3.98%      
Volatility rate         85.00%      
Dividends yield rate         0.00%      
Duration of years         4 years